| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84691 |
1281816-04-3，Lys-Nε-MCC-DM1，ADC定制 |
125 |
wyh |
2024-12-19 |
| 84692 |
cas:34450-18-5，Alkynyl Stearic Acid，17-十八炔酸 |
214 |
zyl |
2024-12-19 |
| 84693 |
Mal-PEG4-Val-Cit-PAB-OH（CAS: 2055041-39-7） |
181 |
WYQ |
2024-12-19 |
| 84694 |
1281816-04-3，Lys-Nε-MCC-DM1，ADC定制 |
142 |
wyh |
2024-12-19 |
| 84695 |
cas:120550-35-8，Biotin-PFP ester，五氟苯酚生物素酯 |
351 |
zyl |
2024-12-19 |
| 84696 |
MTS-ADO3A 三酸DOTA衍生物 |
201 |
h |
2024-12-19 |
| 84697 |
NHS-PEG2-NH-Xanomeline，ADC定制 |
161 |
wyh |
2024-12-19 |
| 84698 |
DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 DOTA-CCK |
207 |
h |
2024-12-19 |
| 84699 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
146 |
h |
2024-12-19 |
| 84700 |
cas:2123482-78-8，TETRAZINE-SS-BIOTIN 四嗪-双硫键-生物素 |
149 |
zyl |
2024-12-19 |
| 84701 |
GG-Tesirine，ADC定制 |
212 |
wyh |
2024-12-19 |
| 84702 |
DOTA-PEG-A20FMDV2 DOTA偶联聚乙二醇化的20个残基的线性肽 |
236 |
h |
2024-12-19 |
| 84703 |
MC-GGFG-Exatecan，ADC定制 |
250 |
wyh |
2024-12-19 |
| 84704 |
亲和素-AMF-DOTA(Nd) |
185 |
h |
2024-12-19 |
| 84705 |
DOTA偶联人血清白蛋白微球 DOTA-HSAM |
321 |
h |
2024-12-19 |
| 84706 |
MC-VA-PBD，MC-Val-Ala-PBD，ADC定制 |
363 |
wyh |
2024-12-19 |
| 84707 |
cas:2241685-22-1，DADPS Biotin Alykne |
169 |
zyl |
2024-12-19 |
| 84708 |
MC-vc-PAB-C6-Alpha-Amanitin，ADC定制 |
168 |
wyh |
2024-12-19 |
| 84709 |
MPB-MMAF，ADC定制 |
231 |
wyh |
2024-12-19 |
| 84710 |
DOTA–Bipy–RuII配位共轭物 |
308 |
h |
2024-12-19 |
| 84711 |
cas:1007215-91-9，1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oic acid |
184 |
zyl |
2024-12-19 |
| 84712 |
DOTA-cT84.66 DOTA偶联单克隆抗体cT84.66 |
161 |
h |
2024-12-19 |
| 84713 |
DOTA-Ahx-(D-Lys(6)-GnRH1)金属螯合剂DOTA偶联氨基己酸缀合D-赖氨酸 |
174 |
h |
2024-12-19 |
| 84714 |
DOTA-LRB 2-(6-(二乙基氨基)-3-(二乙基亚胺基)-3H-呫吨-9-基)-5-(N-(2-(2-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)乙酰胺基 |
182 |
h |
2024-12-19 |
| 84715 |
DOTA-Y3-TATE DOTA偶联激动剂Y3-TATE |
203 |
h |
2024-12-19 |
| 84716 |
DOTA-2-脱氧-D-氨基葡萄糖 DOTA-DG |
207 |
h |
2024-12-19 |
| 84717 |
DOTA-c(RGDfK)DOTA偶联环肽 |
148 |
h |
2024-12-19 |
| 84718 |
SCN-DOTA-PCA DOTA-苯甲酰胺衍生物 |
195 |
h |
2024-12-19 |
| 84719 |
DOTA-N-羟基琥珀酰亚胺 DOTA-N-hydroxysuccinimide |
175 |
h |
2024-12-19 |
| 84720 |
低分子量CLT1肽靶向Gd(III)螯合物CLT1-dL-(Gd-DOTA) |
258 |
h |
2024-12-19 |
| 84721 |
DOTA-1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺脂质 |
237 |
h |
2024-12-19 |
| 84722 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA17,19) |
179 |
h |
2024-12-19 |
| 84723 |
cas:1061569-06-9，4-formyl-N-(2-(2-hydroxyethoxy)ethyl)benzamide ADC抗体偶联药物 |
142 |
zyl |
2024-12-19 |
| 84724 |
DBCO-PEG4-VA-PBD，2241644-09-5，ADC定制 |
130 |
wyh |
2024-12-19 |
| 84725 |
Val-Cit-PAB-MMAE，cas:644981-35-1，ADC定制 |
169 |
wyh |
2024-12-19 |
| 84726 |
DOTA-GMSH 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联α-黑素细胞刺激素(α-MSH)类似物 |
235 |
h |
2024-12-19 |
| 84727 |
mDPR-Val-Cit-PAB-MMAE，1491152-26-1，ADC定制 |
141 |
wyh |
2024-12-19 |
| 84728 |
G3-(Gd-DTPA)(24)DOTA-钆(Gd)大分子造影剂 |
360 |
h |
2024-12-19 |
| 84729 |
DOTA-多柔比星 DOTA-DOX |
191 |
h |
2024-12-19 |
| 84730 |
聚(HPMA)-c(RGDyK)-DOTA |
131 |
h |
2024-12-19 |
| 84731 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭的应变环辛烯衍生物二苄基环辛烯(DBCO) |
167 |
h |
2024-12-19 |
| 84732 |
PDDEC-NB；2-methyl-2-(pyridin-2-yldisulfanyl)propyl 4-nitrophenyl carbonate |
128 |
zyl |
2024-12-19 |
| 84733 |
(67)Ga-DOTA复合物共轭二膦酸盐(67)Ga-DOTA-Bn-SCN-HBP |
203 |
h |
2024-12-19 |
| 84734 |
MWCNT/PEI-FI-DOTA(Gd)-PEG 异硫氰酸荧光素(FI)和钆(Gd)螯合剂共价接枝聚乙烯亚胺修饰的多壁碳纳米管 |
195 |
h |
2024-12-19 |
| 84735 |
DOTA-Cys-hAb47 螯合剂DOTA偶联半胱氨酸-抗EphB4抗体hAb47和hAb131 |
242 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询